Inventor · disambiguated record
Nicholas P. Restifo
Also filed as: RESTIFO I NICHOLAS · RESTIFO NICHOLAS · RESTIFO NICHOLAS P
28 granted patents·21 pending applications·328 citations·filing 1995–2024
96Inventor score
Top patents by PatentIndex Score
49 records- 0198US10166255B2Intracellular genomic transplant and methods of therapyUNIV MINNESOTA·Filed 2016·Granted Jan 1, 2019·43 cites·31 claims
- 0296US11266692B2Intracellular genomic transplant and methods of therapyUNIV MINNESOTA·Filed 2020·Granted Mar 8, 2022·3 cites·19 claims
- 0396US11154574B2Tumor infiltrating lymphocytes and methods of therapyUNIV MINNESOTA·Filed 2020·Granted Oct 26, 2021·8 cites·12 claims
- 0496US10406177B2Modified cells and methods of therapyUNIV MINNESOTA·Filed 2016·Granted Sep 10, 2019·18 cites·23 claims
- 0594US11147837B2Modified cells and methods of therapyUNIV MINNESOTA·Filed 2016·Granted Oct 19, 2021·6 cites·49 claims
- 0693US8216565B2GP100-specific T cell receptors and related materials and methods of useRESTIFO NICHOLAS P·Filed 2008·Granted Jul 10, 2012·32 cites·9 claims
- 0793US8012490B2Recombinant influenza viruses expressing tumor-associated antigens as antitumor agentsSINAI SCHOOL MEDICINE·Filed 2009·Granted Sep 6, 2011·10 cites·13 claims
- 0892US10912797B2Tumor infiltrating lymphocytes and methods of therapyUNIV MINNESOTA·Filed 2018·Granted Feb 9, 2021·9 cites·33 claims
- 0992US8556882B2Inducible interleukin-12MORGAN RICHARD A·Filed 2010·Granted Oct 15, 2013·30 cites·26 claims
- 1090US8613932B2GP100-specific T cell receptors and related materials and methods of useRESTIFO NICHOLAS P·Filed 2012·Granted Dec 24, 2013·12 cites·8 claims
- 1188US5733548AImmunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatmentsUS GOV HEALTH & HUMAN SERV·Filed 1995·Granted Mar 31, 1998·80 cites·16 claims
- 1283US11723923B2Methods of preparing T cells for T cell therapyKITE PHARMA INC·Filed 2019·Granted Aug 15, 2023·2 cites·12 claims
- 1381US2022362297A1Intracellular genomic transplant and methods of therapyUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 1481US2025002851A1Methods of preparing t cells for t cell therapyKITE PHARMA INC·Filed 2024·Application pending·0 cites
- 1580US2022125843A1Modified cells and methods of therapyUNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 1678US2024009243A1Methods of preparing t cells for t cell therapyKITE PHARMA INC·Filed 2023·Application pending·0 cites
- 1776US11903966B2Intracellular genomic transplant and methods of therapyUNIV MINNESOTA·Filed 2018·Granted Feb 20, 2024·0 cites·46 claims
- 1876US11642375B2Intracellular genomic transplant and methods of therapyUNIV MINNESOTA·Filed 2018·Granted May 9, 2023·0 cites·31 claims
- 1976US11642374B2Intracellular genomic transplant and methods of therapyUNIV MINNESOTA·Filed 2018·Granted May 9, 2023·0 cites·17 claims
- 2076US11583556B2Modified cells and methods of therapyUNIV MINNESOTA·Filed 2020·Granted Feb 21, 2023·0 cites·8 claims
- 2175US5856187AImmunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatmentsUS HEALTH·Filed 1995·Granted Jan 5, 1999·35 cites·15 claims
- 2274US5846540AImmunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatmentsUS HEALTH·Filed 1995·Granted Dec 8, 1998·36 cites·24 claims
- 2373US11898166B2In vitro generation of thymic organoid from human pluripotent stem cellsUS HEALTH·Filed 2018·Granted Feb 13, 2024·1 cites·13 claims
- 2473US10316289B2Methods of producing T memory stem cell populationsGATTINONI LUCA·Filed 2012·Granted Jun 11, 2019·3 cites·12 claims
- 2573US2022105133A1Tumor infiltrating lymphocytes and methods of therapyUNIV MINNESOTA·Filed 2021·Application pending·0 cites
- 2668US11111478B2Methods of producing T memory stem cell populationsUS HEALTH·Filed 2019·Granted Sep 7, 2021·0 cites·4 claims
- 2767US2020330517A1Tumor infiltrating lymphocytes and methods of therapyUNIV MINNESOTA·Filed 2020·Application pending·0 cites
- 2867US2025154458A1Methods for Making, Compositions Comprising, and Methods of Using Rejuvenated T CellsLYELL IMMUNOPHARMA INC·Filed 2024·Application pending·0 cites
- 2964US2025122473A1Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using sameTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2024·Application pending·0 cites
- 3063US9522948B2GP100-specific T cell receptors and related materials and methods of useUS HEALTH·Filed 2013·Granted Dec 20, 2016·0 cites·14 claims
- 3162US12091682B2Methods for making, compositions comprising, and methods of using rejuvenated T cellsLYELL IMMUNOPHARMA INC·Filed 2021·Granted Sep 17, 2024·0 cites·32 claims
- 3261US2005100558A1Heterologous boosting immunizationsUS GOV HEALTH & HUMAN SERV·Filed 2004·Application pending·0 cites
- 3358US12415845B2Methods of producing T cell populations using hydroxycitric acid and/or a salt thereofUS HEALTH·Filed 2019·Granted Sep 16, 2025·0 cites·10 claims
- 3457US12365871B2Methods for culturing cellsLYELL IMMUNOPHARMA INC·Filed 2021·Granted Jul 22, 2025·0 cites·32 claims
- 3554US2022282208A1Methods of isolating t cell populationsPALMER DOUGLAS C·Filed 2020·Application pending·0 cites
- 3652US2023265508A1PREFERENTIAL GENERATION OF iPSC CARRYING ANTIGEN SPECIFIC TCRs FROM TUMOR INFILTRATING LYMPHOCYTESUS HEALTH·Filed 2021·Application pending·0 cites
- 3752US2023131219A1Use of agonists to augment car t function in solid tumorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Application pending·0 cites
- 3851US12215349B2Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using sameUS HEALTH·Filed 2017·Granted Feb 4, 2025·0 cites·10 claims
- 3950US2017136063A1Methods of Preparing T Cells for T Cell TherapyKITE PHARMA INC·Filed 2016·Application pending·0 cites
- 4050US2001036928A1Heterologous boosting immunizationsFiled 2001·Application pending·0 cites
- 4148US2015275209A1Compositions and methods for enhancing cancer immunotherapyUS HEALTH·Filed 2013·Application pending·0 cites
- 4247US2021214415A1Immunoresponsive cells expressing dominant negative fas and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 4346US2023036952A1Methods of producing t cell populations using induced pluripotent stem cellsUS HEALTH·Filed 2021·Application pending·0 cites
- 4446US2022175834A1Methods for culturing immune cellsLYELL IMMUNOPHARMA INC·Filed 2021·Application pending·0 cites
- 4546US2024228957A9Methods for culturing cellsLYELL IMMUNOPHARMA INC·Filed 2022·Application pending·0 cites
- 4644US2019374576A1Viral methods of t cell therapyINTIMA BIOSCIENCE INC·Filed 2019·Application pending·0 cites
- 4743US12037607B2Methods of preparing hematopoietic progenitor cells in vitroUS HEALTH·Filed 2018·Granted Jul 16, 2024·0 cites·13 claims
- 4839US2020316122A1Methods of producing t cell populations using p38 mapk inhibitorsUS HEALTH·Filed 2018·Application pending·0 cites
- 4937US11312998B2Methods for selecting therapy for a cancer patientUS HEALTH·Filed 2017·Granted Apr 26, 2022·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Nicholas P. Restifo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →